Evidence map›Paper›PMID 26524976›Full record

ArticleImmunology2016

CD74/DQA1 dimers predispose to the development of arthritis in humanized mice.

Luckey David, Ameya Gokhale, Seetharama Jois, Aaron Johnson, Marshall Behrens, Harvinder Luthra, Veena Taneja

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Luckey DavidDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Ameya GokhaleDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA.
Seetharama JoisDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA.
Aaron JohnsonDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Marshall BehrensDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Harvinder LuthraDivision of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Veena TanejaDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic · USMayo Clinic in Arizona · USUniversity of Louisiana at Monroe · USWinnMed · US

Funding

STABILITY' (symptomatic review during biologic therapy) Review in Inflammatory Bowel DiseaseP20GM103424 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI Seetharama D Jois · 2012 to 2026
$57.4M
IMMUNOGENETICS OF COLLAGEN-INDUCED ARTHRITIS IN MICER01AR030752 · NIAMS · MAYO CLINIC ROCHESTER · PI DAVID, CHELLA S, TANEJA, VEENA · 1987 to 2014
$4.3M
Role of B cells in pathogenesis of Collagen-induced Arthritis in Humanized MiceR01AI075262 · NIAID · MAYO CLINIC ROCHESTER · PI TANEJA, VEENA · 2009 to 2012
$1.2M
Immunogenetics of Collagen Induced Arthritis in MiceR56AR030752 · NIAMS · MAYO CLINIC ROCHESTER · PI DAVID, CHELLA S, TANEJA, VEENA · 2009 to 2009
$325k
NIAID NIH HHS AI075262NIAID NIH HHS R01 AI075262NIAMS NIH HHS AR30752NIAMS NIH HHS R01 AR030752NIAMS NIH HHS R56 AR030752NIGMS NIH HHS 8P20GM103424NIGMS NIH HHS P20 GM103424
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is associated with the presence of certain HLA class II genes. However, why some individuals carrying RA non-associated alleles develop arthritis is still unexplained. The trans-heterodimer between two RA non-associated HLA genes can render susceptibility to develop arthritis in humanized mice, DQA1*0103/DQB1*0604, suggesting a role for DQ α chains in pathogenesis. In this study we determined the role of DQA1 in arthritis by using mice expressing DQA1*0103 and lacking endogenous class II molecules. Proximity ligation assay showed that DQA1*0103 is expressed on the cell surface as a dimer with CD74. Upon immunization with type II collagen, DQA1*0103 mice generated an antigen-specific cellular and humoral response and developed severe arthritis. Structural modelling suggests that DQA1*0103/CD74 form a pocket with similarity to the antigen binding pocket. DQA1*0103 mice present type II collagen-derived peptides that are not presented by an arthritis-resistant DQA1*0103/DQB1*0601 allele, suggesting that the DQA1*0103/CD74 dimer may result in presentation of unique antigens and susceptibility to develop arthritis. The present data provide a possible explanation by which the DQA1 molecule contributes to susceptibility to develop arthritis.

Indexed as

AnimalsAntigen PresentationAntigens, Differentiation, B-LymphocyteArthritis, ExperimentalBinding SitesCell MembraneCell ProliferationCells, CulturedCollagen Type IIFemaleHistocompatibility Antigens Class IIHLA-DQ alpha-ChainsHumansImmunity, CellularImmunity, HumoralLymphocyte ActivationAntigens, Differentiation, B-LymphocyteCollagen Type IIHistocompatibility Antigens Class IIHLA-DQA1 antigenHLA-DQ alpha-Chainsinvariant chainCD74DQA1*0103heterodimerhumanized micerheumatoid arthritis

Identifiers

PMID26524976
PMCPMC4717240
OpenAlexW1958830417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.